Renesas Electronics Corporation ( OTCPK:RNECF) Q4 2024 Earnings Call February 5, 2025 8:00 PM ET Hidetoshi Shibata - President and Chief Executive Officer Shuhei Shinkai - Senior Vice President and ...

Choose from Net Revenue Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...

picture alliance / dpa Profit and revenue decreased in the nine-month period from April to December for Japanese camera and optics manufacturer Nikon compared to the same period of the previous year.

Tele2 TEL2.B0.36%increase; green up pointing triangle said it plans to reduce its workforce as part of its cost-reduction strategy despite reporting higher net profit for the fourth quarter on ...

Blue Orca Capital announced a short position in Teladoc (TDOC), saying evidence shows that even though patients on the BetterHelp platform pay ...

An icon in the shape of a lightning bolt. Impact Link Another Jeff Bezos-founded company wants fewer middle managers. Bezos' rocket company, Blue Origin, said on Thursday that it was laying off ...

Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity, is part of a class of drugs known as GLP-1 receptor agonists, mimicking the hormone GLP-1 to reduce ...

Explore key insights from ICON's Q4 2024 earnings call, including bookings growth, digital innovation, and strategic partnerships driving 2025 growth targets.

The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of analysts' expectations of $8.56 per share, according to data compiled by LSEG. The ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...